Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
Browsing: wins
Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
Eli Lilly wins buy as Citi resumes coverage on obesity prospects Source: Seekingalpha
Roche wins FDA approval for Ocrevus Zunovo as twice yearly multiple sclerosis therapy Source: Seekingalpha
Roche wins FDA nod for Tecentriq version developed with Halozyme Source: Seekingalpha
Eli Lilly wins buy as Citi resumes coverage on obesity prospects Source: Seekingalpha
Rafael_Wiedenmeier/iStock Unreleased by way of Getty Images The U.S. FDA has accredited Roche’s (OTCQX:RHHBY) Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) as a twice a yr subcutaneous injection…
Roche wins FDA nod for Tecentriq version developed with Halozyme Source: Seekingalpha
Ensysce wins $14M federal grant for lead pain therapy Source: Seekingalpha
Ensysce wins $14M federal grant for lead pain therapy Source: Seekingalpha